[DOI] [PubMed] [Google Scholar] 115.Berg S., Krause J., Bjrkbom A., Walter K., Harun S., Granfeldt A., Janzn D., Nunes S.F., Antonsson M., Van Zuydam N., et al
He led the landmark STEP clinical trials for Novo Nordisk that brought semaglutide to market, co-authored the influential Lancet Commission framework distinguishing clinical from preclinical obesity, and has written multiple books on the subject including a phenotype-based guide for clinicians and the popular Six Factors to Fit
While the FDA has received reports of anxiety in some users, real-world data suggests a relatively low incidence of adverse psychiatric events
Statements Author contributions XD: Conceptualization, Writing original draft, Writing review and editing, Validation, Visualization